Global Cell Sorting Market Size

Cell Sorting Market Analysis

The cell sorting market is expected to register a CAGR of nearly 7.3% during the forecast period.

Due to the pandemic, all the research and development programs have been only for developing drugs and vaccines related to the coronavirus, and all other programs have come to a halt. Many biotech and pharma companies have stopped producing due to the lack of labor during the lockdown globally. The growing market has not been as expected due to the companies' disruption of research programs and less procurement of cell sorters.

The cell sorting market will show rapid growth due to the growing prevalence of HIV and cancer, expanding pharmaceutical and biotechnology industries, and technological advancements in cell sorters.

HIV continues to be a major global public health issue. The vast majority of people living with HIV are located in low- and middle-income countries. According to UnAIDs, 2020 estimates, around 38.0 million people globally had AIDS as of 2019. 1.7 million got newly infected.

Over the years, cell sorting was combined with molecular biological techniques and proteomics for characterizing metastatic and primary cancer cell populations and single tumor cells. According to Globocan, 19.29 million people got newly diagnosed with cancer for the year 2020. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the United States, and 606,520 people died due to the disease as per National Cancer Institute. With the growing prevalence of cancer, the demand for cell sorters also increases for characterizing tumors.

However, the high cost of the devices and the lack of awareness of the advantages of these cell sorters restrain the market in the forecast period.